Month: March 2023

In a first, Merck has secured a full approval for Keytruda in a tumor agnostic setting — as a treatment for any unresectable or metastatic solid tumors that are classified as microsatellite instability-high (MSI-H) or […]

The Leading Retailer of Premium Arch Supports Teams Up with the Two-Time Cup Series Champion to Highlight the Importance of Foot Health for Athletes and Elevating Total Body Health CARLSBAD, Calif., March 30, 2023 /PRNewswire/ […]

SAN DIEGO, March 30, 2023 /PRNewswire/ — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information […]

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana Reeve Foundation, a non-profit organization […]

SAN DIEGO–(BUSINESS WIRE)– #Fortune–Scientist.com named America’s 11th Most Innovative Company by Fortune for transforming how preclinical research is done within biopharma industry. Click here to view original post

SAN DIEGO, March 29, 2023 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its […]

CARLSBAD, Calif., March 29, 2023 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced… […]

SAN DIEGO, March 29, 2023 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it intends to […]

SAN DIEGO, March 29, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that the […]

Phase 1b study showed dose-dependent and sustained reduction of tau protein in cerebrospinal fluid through open-label long-term extension (LTE) IONIS-MAPTRx reduced aggregated tau pathology across all brain composites assessed starting as early as week 25 […]

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced an upcoming presentation highlighting […]

SAN DIEGO–(BUSINESS WIRE)–The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital (NASDAQ: WDC) to create and […]

SAN DIEGO and ADELAIDE, Australia, March 28, 2023 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO), has been awarded a $5 million AUD grant under the Federal Government’s Medical Research Future Fund […]

SAN DIEGO, March 28, 2023 /PRNewswire/ — Cymbiotika, the leading supplement brand known for creating clean, science-backed supplements, announced its newest product, Matcha. Used ceremonially in Japan, matcha is the standard of green tea leaves. […]

Azure customers worldwide now have access to MedCrypt’s cryptography API solution, Guardian, which allows manufacturers to build cryptography directly into medical devices SAN DIEGO, March 28, 2023 /PRNewswire/ — MedCrypt, Inc., the proactive cybersecurity solution […]

In May, the Ferring Research Institute in San Diego will let all 89 of its employees go. Led by SVP of global drug discovery and external innovation Araz Raoof, the institute works on small molecule […]

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the life science industry of California, issued the following statement regarding their application to intervene in support of Illumina’s challenge […]

Viking Therapeutics will enter the next phase of the GLP-1 weight loss race, as the small biotech touted early data showing its investigational drug led to a drop of as much as 6% more body […]

SAN DIEGO, March 28, 2023 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers, today announced […]

SAN DIEGO–(BUSINESS WIRE)– #INDenabling–Selvita joins Scientist.com’s new IND enabling pipeline program, giving pre-clinical researchers greater access to IND-enabling studies. Click here to view original post

Up to 6.0% Placebo-Adjusted Mean Weight Loss (7.8% From Baseline) Observed After 28 Days VK2735 Shown to be Safe and Well-Tolerated in 28-Day Study Phase 2 Trial in Obesity Planned for Mid-2023 SAN DIEGO, March […]

As demand for clinical next-generation sequencing grows, Illumina Connected Insights enables user to streamline data interpretation and report generation to inform precision care SAN DIEGO, March 27, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a […]

Data collected via the SYNTap® test will be presented, highlighting recent findings in the identification of patients with Lewy body pathology SYNTap® addresses the urgent need for a highly specific diagnostic tool for Lewy Body […]